Sophie Girod-Dupuis

Bron, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 102 publications

Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.

Functional and Molecular Characterization of Novel GDF2 (BMP9) and BMP10 Variants From the French PAH and HHT Cohorts.

Journal: Circulation. Genomic and precision medicine

Published: June 09, 2026

Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia.

Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia.

Journal: The New England journal of medicine

Published: November 26, 2025

Executive summary of the 15th HHT international scientific conference.

Executive summary of the 15th HHT international scientific conference.

Journal: Angiogenesis

Published: November 18, 2025

A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study.

A contemporary picture of bacterial infections in patients with hereditary hemorrhagic telangiectasia: A nationwide cohort study.

Journal: The Journal of infection

Published: October 23, 2025

Pulmonary hypertension associated with hereditary haemorrhagic telangiectasia: from genetics to clinical management.

Pulmonary hypertension associated with hereditary haemorrhagic telangiectasia: from genetics to clinical management.

Journal: The European respiratory journal

Published: July 22, 2025

Loss of function variants in ADAMTS6 : Connective tissue, Heart defect, thoracic Aortic aneurysm and Neuro developmental Syndrome (CHANS).

Loss of function variants in ADAMTS6 : Connective tissue, Heart defect, thoracic Aortic aneurysm and Neuro developmental Syndrome (CHANS).

Journal: medRxiv : the preprint server for health sciences

Published: July 14, 2025

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.

Journal: British journal of clinical pharmacology

Published: June 11, 2025

Overlapping upstream ORFs ending at c.125 lead to reduced Endoglin, contributing to Hereditary Hemorrhagic Telangiectasia.

Overlapping upstream ORFs ending at c.125 lead to reduced Endoglin, contributing to Hereditary Hemorrhagic Telangiectasia.

Journal: Communications biology

Published: April 23, 2025

Development of a functional assay for the characterisation of SMAD4 variants from the French haemorrhagic hereditary telangiectasia cohort.

Development of a functional assay for the characterisation of SMAD4 variants from the French haemorrhagic hereditary telangiectasia cohort.

Journal: Journal of medical genetics

Published: March 24, 2025

Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.

Efficacy of Irbesartan in Celiprolol-Treated Patients With Vascular Ehlers-Danlos Syndrome.

Journal: Circulation

Published: February 05, 2025

Hereditary haemorrhagic telangiectasia.

Hereditary haemorrhagic telangiectasia.

Journal: Nature reviews. Disease primers

Published: November 29, 2024

Family planning, sexual activity and contraception in hereditary hemorrhagic telangiectasia: a European survey study.

Family planning, sexual activity and contraception in hereditary hemorrhagic telangiectasia: a European survey study.

Journal: Orphanet journal of rare diseases

Published: September 10, 2024

Showing 1-12 of 102

Last Updated: 09/26/2026